Vagal sensory neurons drive mucous cell metaplasia - 08/06/20
Doi : 10.1016/j.jaci.2020.01.003
Sébastien Talbot, PhD a, b, c 
, Benjamin Doyle, MSc a, b, Junwei Huang, PhD a, b, Jo-Chiao Wang, MSc c, Maryam Ahmadi, MSc c, David P. Roberson, PhD a, b, Ajay Yekkirala, PhD a, b, Simmie L. Foster, MD, PhD a, b, Liam E. Browne, PhD a, b, d, Bruce P. Bean, PhD b, Bruce D. Levy, MD e, Clifford J. Woolf, MB, BCh, PhD a, b
, Benjamin Doyle, MSc a, b, Junwei Huang, PhD a, b, Jo-Chiao Wang, MSc c, Maryam Ahmadi, MSc c, David P. Roberson, PhD a, b, Ajay Yekkirala, PhD a, b, Simmie L. Foster, MD, PhD a, b, Liam E. Browne, PhD a, b, d, Bruce P. Bean, PhD b, Bruce D. Levy, MD e, Clifford J. Woolf, MB, BCh, PhD a, b a FM Kirby Neurobiology Center, Children's Hospital Boston, Boston, Mass
b Department of Neurobiology, Harvard Medical School, Boston, Mass
c Département de Pharmacologie et Physiologie, Université de Montréal, Montréal, Québec, Canada
d Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
e Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass
| This work was partially supported by the National Institute of Health (grants PO1NS072040 to C.J.W. and B.P.B. and HL122531 to B.D.L.); the Canadian Institutes of Health Research (S.T., 407016), the Canadian Foundation for Innovation (S.T., 37439), Canada Research Chair program (S.T., 950-231859), Natural Sciences and Engineering Research Council of Canada (S.T.; RGPIN-2019-06824) and the Brain Canada Foundation, Health Canada and the Azrieli Foundation (S.T.); and a European Commission fellowship (L.E.B.; 329202) and a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (L.E.B.; 109372/Z/15/Z). JCW received a Bastable-Potts Graduate research award from Asthma Canada and the Canadian Allergy, Asthma and Immunology Foundation. |
|
| Disclosure of potential conflict of interest: S. Talbot, D. Roberson, B. P. Bean, B. D. Levy, and C. J. Woolf, each have an equity stake in Nocion Therapeutics. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 145 - N° 6
P. 1693 - Giugno 2020 Ritorno al numero
Articolo precedente
- CRISPR gene-engineered CYBBko THP-1 cell lines highlight the crucial role of NADPH-induced reactive oxygen species for regulating inflammasome activation
- Aissa Benyoucef, Lorie Marchitto, Fabien Touzot
- Severe combined immunodeficiency caused by inositol-trisphosphate 3-kinase B (ITPKB) deficiency
- Abduarahman Almutairi, Jacqueline G. Wallace, Faris Jaber, Mohammed F. Alosaimi, Jennifer Jones, Mohamed T.H. Sallam, M.H. Elnagdy, Janet Chou, Ali Sobh, Raif S. Geha
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?